Despite intensive study, many mysteries remain about the MYCN oncogene's functions. Here we focus on MYCN's role in neuroblastoma, the most common extracranial childhood cancer. MYCN gene amplification occurs in 20% of cases, but other recurrent somatic mutations are rare. This scarcity of tractable targets has hampered efforts to develop new therapeutic options. We employed a multilevel omics approach to examine MYCN functioning and identify novel therapeutic targets for this largely un-druggable oncogene. We used systems medicine based computational network reconstruction and analysis to integrate a range of omic techniques: Sequencing-based transcriptomics, genome-wide chromatin immunoprecipitation, siRNA screening and interaction proteo...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
Background: Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, ...
Despite intensive study, many mysteries remain about the MYCN oncogene's functions. Here we focus on...
Despite intensive study, many mysteries remain about the MYCN oncogene's functions. Here we focus on...
Despite intensive study, many mysteries remain about the MYCN oncogene\u27s functions. Here we focus...
Neuroblastoma is the first neurogenic-extracranial solid cancer occurring in infancy and childhood. ...
MYCN, an oncogenic transcription factor of the Myc family, is a major driver of neuroblastoma tumori...
Neuroblastoma is a highly genetically heterogeneous form of paediatric cancer with clinical behaviou...
Although a rare disease, neuroblastoma accounts for the highest proportion of childhood cancer death...
Background: Neuroblastic tumors are often addicted to the MYCN protooncogene. Results: Using a genom...
Neuroblastoma is a highly genetically heterogeneous form of paediatric cancer with clinical behaviou...
BACKGROUND: Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, ...
BACKGROUND:Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, i...
Amplification of the locus encoding the oncogenic transcription factor MYCN is a defining feature of...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
Background: Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, ...
Despite intensive study, many mysteries remain about the MYCN oncogene's functions. Here we focus on...
Despite intensive study, many mysteries remain about the MYCN oncogene's functions. Here we focus on...
Despite intensive study, many mysteries remain about the MYCN oncogene\u27s functions. Here we focus...
Neuroblastoma is the first neurogenic-extracranial solid cancer occurring in infancy and childhood. ...
MYCN, an oncogenic transcription factor of the Myc family, is a major driver of neuroblastoma tumori...
Neuroblastoma is a highly genetically heterogeneous form of paediatric cancer with clinical behaviou...
Although a rare disease, neuroblastoma accounts for the highest proportion of childhood cancer death...
Background: Neuroblastic tumors are often addicted to the MYCN protooncogene. Results: Using a genom...
Neuroblastoma is a highly genetically heterogeneous form of paediatric cancer with clinical behaviou...
BACKGROUND: Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, ...
BACKGROUND:Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, i...
Amplification of the locus encoding the oncogenic transcription factor MYCN is a defining feature of...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
Background: Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, ...